Institutes outside Greece
Posttranscriptional regulation of the components of the human leukocyte antigen class I antigen processing and presentation machinery as an immune escape mechanism in melanoma
Abstract
dc:descriptionTumours are characterised by an aberrant cell proliferation rate along with the potential to invade or spread to other parts of the body. Melanoma is acknowledged as one of the most immunogenic types of human tumours. “Avoiding immune destruction” is a key hallmark of cancer cells which can be accomplished via several immune escape mechanisms limiting their recognition and destruction by either CD8+ T- or NK cells. Such tumour-mediated escape mechanisms can be associated with structural alterations, epigenetic modulations, loss of heterozygosity as well as posttranscriptional or posttranslational regulation mechanisms of genes associated with the HLA-I APM thereby limiting the HLA-I surface expression levels. In regard to the HLA-I APM, in particular the TAP subunits TAP1 and TAP2 along with the chaperone TPN are functionally critical components for the binding of peptide fragments, since TAP stabilizes the HC/β2-m heterodimers and TPN facilitates the peptide loading onto empty HLA-I molecules. However, in addition to the presentation of such antigenic peptide ligands in combination with classical HLA-I molecules to CD8+ T-cells, presentation of non-classical HLA-I molecules mediating inhibitory stimuli to NK cells can be involved in limiting cellular immune responses. In the context of the current thesis, the aspects of posttranscriptional regulations of HLA-I APM components by miRs and RBPs were analysed in more detail, since a heterogeneous and discordant mRNA and protein expression pattern of several HLA-I APM components, including TAP1, TAP2, TPN next to the HLA-I surface expression rate has been frequently described in tumours of distinct origin, including several in-house extensively characterized human melanoma cell lines. Thus, it was of great interest to define miRs and RBPs which can affect the expression of such immune regulatory molecules in tumour and immune cells, thereby leading to the escape of tumour cells from the immune surveillance or at least lowering their immune response capacity. Based on the successful identification of novel miRs and RPBs by performing high throughput analyses in combination with the miTRAP and RNA-AP assays, respectively the focus was set on defining posttranscriptional regulators of TAP1, TAP2 or TPN, targeting the respective 3’-UTRs. Moreover, the specific binding of the candidate miRs miR-200a-5p, miR-26b-5p and miR-21-3p to the TAP1 3’-UTR have been successfully confirmed via dual luciferase reporter assays. In addition, the expression rates of selected candidate miRs were not only correlated with the corresponding protein expression rates in a panel of model cell lines but also in a series of primary melanoma lesions along with their associations with relevant clinical parameters. Furthermore, their impact in regard to the susceptibility to undergo lysis be either CD8+ T- or NK cells were assessed. The presented data show that miR-mediated modulations of APM components can be associated with altered immune recognition pattern thereby having an impact on overall survival rates of melanoma patients. Thus, miR-200a-5p, miR-26-5p and miR-21-3p, together with miR-9-5p might be worth to be considered as potential future candidate biomarkers or eventually even could be further developed towards novel therapeutic targets for melanoma patients. Aside from these miR targets also a set of candidate RBPs was successfully identified which bind to either the 3’-UTRs of TAP1 or TPN, respectively. Amongst them, the roles of the candidate RBPs IGF2BP1 and IGF2BP3 have been characterized in more detail. Next to their impact on the modulation of the expression rates of the targeted APM components and on overall HLA-I surface expression levels. For IGF2BP transfectants comparative proteomic profilings versus respective controls resulted even in the successful identification of differentially expressed proteins which could further linked to functional networks, thereby implying that the dysregulation of these RBPs might be worthy to be addressed in further studies. Taken together, by the identification of these novel immune modulatory miRs and RBPs targeting TAP1, TAP2 or TPN, this study underlines the importance of the initially proposed posttranscriptional control mechanisms for HLA-I APM components and their likely role in contributing at least to some extent to the frequently observed immune escape promoting tumour growth. These molecules might thus be used as novel predictive markers or even as targets for future combinatorial cancer immunotherapy approaches.
Degree
thesis:*- Grantor dc:publisher
- Institutes outside Greece
- Year dc:date
- 2021
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Lazaridou, Maria-Filothei
- Λαζαρίδου, Μαρία-Φιλοθέη
Subjects
dc:subject × 19- Μελάνωμα
- Αντιγόνα ιστοσυμβατότητας HLA τάξης Ι
- Μεταμεταγραφική ρύθμιση γονιδιακής έκφρασης
- Melanoma
- HLA-class-I
- Posttranscriptional regulation of gene expression
- Melanom
- HLA der Klasse I
- Posttranskriptionelle Regulation der Genexpression
- Χημεία
- Φυσικές Επιστήμες
- Χημεία, άλλοι τομείς
- Βιολογία
- Βιοχημεία και Μοριακή βιολογία
- Chemical Sciences
- Natural Sciences
- Chemistry, miscellaneous
- Biological Sciences
- Biochemistry and Molecular Biology
Rights
- Language dc:language
- eng
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/58138